China's inactivated Covid-19 vaccine shows promising results

BEIJING (Xinhua): China has unveiled the results of the phase 1 and phase 2 clinical trials of an inactivated Covid-19 vaccine candidate, which shows promising results in both safety and efficacy, according to the China National Pharmaceutical Group (Sinopharm).

The vaccine, developed by the Wuhan Institute of Biological Products under the China National Biotec Group (CNBG) affiliated to Sinopharm, involved 1,120 volunteers aged between 18 and 59 in its clinical trials, which started on April 12.